Listed by the USPTO as MATALKAH, FATIMAH KHALAF
Tech Center 1600 • Art Units: 1632 1638
This examiner grants 56% of resolved cases
MATALKAH, FATIMAH KHALAF works in Tech Center 1600 and Art Unit 1632. The record covers 43 resolved cases, with a 55.8% allowance rate and a 1334-day median to allowance. The 27.4% interview lift is notable in this record, suggesting that interviews may be especially relevant when applicants need to clarify claim scope or distinguish cited art.
The recurring companies are The Regents of the University of California, Trustees of Boston University, and Ricoh Company, Ltd. Listed firms include PABST PATENT GROUP LLP, Adams & Reese LH, and ARENTFOX SCHIFF LLP. Because the resolved-case base is limited, practitioners should treat the metrics as directional and supplement them with application-specific review.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18332380 | GENERATION OF NEXT GENERATION RECOMBINANT AAV GENE THERAPY VECTORS THAT ADOPT 3D CONFORMATION | Final Rejection | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 18566782 | ASSAY FOR EXTRINSIC INHIBITION | Non-Final OA | The Regents of The University of California |
| 18278771 | EXTRACELLULAR VESICLES DERIVED FROM INDUCED PLURIPOTENT AND EMBRYONIC STEM CELLS, AND METHODS OF USE FOR IMMUNE MODULATION | Final Rejection | The Regents of the University of California |
| 17911306 | COMPOSITIONS AND METHODS FOR PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS | Final Rejection | The Regents of the University of California |
| 18412130 | CELL CULTURE METHOD, CELL CULTURE CONTAINER, METHOD FOR PRODUCING CELL CULTURE CONTAINER, AND CELL-CONTAINING STRUCTURE | Final Rejection | RICOH COMPANY, LTD. |
| 18559921 | ANELLOVECTORS AND METHODS OF USE | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS V, INC. |
| 17793287 | INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF | Final Rejection | TRUSTEES OF BOSTON UNIVERSITY |
| 18690101 | METHODS AND FORMULATIONS RELATED TO THE INTRATHECAL DELIVERY OF ONCOLYTIC VIRUSES | Non-Final OA | THE UAB RESEARCH FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy55.8% of resolved applications examined by Fatimah Khalaf Matalkah were allowed (43 resolved cases), compared with 38.1% across Art Unit 1632 over the last five years.
This examiner's interview lift is +27.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Fatimah Khalaf Matalkah took 1,334 days on average from filing to allowance.
Fatimah Khalaf Matalkah examines applications in Art Unit 1632 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
